168 related articles for article (PubMed ID: 2408452)
41. [Change in the influenza virus upon multiplication in the presence of high concentrations of remantadine].
Karako NI; Boreko EI; Kirillov VA; Votiakov VI
Vopr Virusol; 1989; 34(1):43-6. PubMed ID: 2728406
[TBL] [Abstract][Full Text] [Related]
42. Vaccination as a strategy to reduce the emergence of amantadine- and rimantadine-resistant strains of A/Chick/Pennsylvania/83 (H5N2) influenza virus.
Webster RG; Kawaoka Y; Bean WJ
J Antimicrob Chemother; 1986 Oct; 18 Suppl B():157-64. PubMed ID: 3793657
[TBL] [Abstract][Full Text] [Related]
43. [Comparative study of the polypeptide composition of influenza A viruses sensitive and resistant to remantadine].
L'vov ND; Vladimirtseva EA; Pushkarskaia NL; Nochemasova ZN
Vopr Virusol; 1981; (5):537-41. PubMed ID: 7336680
[TBL] [Abstract][Full Text] [Related]
44. [Change in the sensitivity of influenza virus, replicating in the presence of rimantadine, to antiviral agents].
Boreko EI; Pavlova NI; Votiakov VI
Vopr Virusol; 1999; 44(3):115-9. PubMed ID: 10392434
[TBL] [Abstract][Full Text] [Related]
45. [Polypeptides from influenza virus, obtained in the presence of high concentrations of rimantadine].
Boreko EI; Pavlova NI; Votiakov VI
Vopr Virusol; 1998; 43(6):270-4. PubMed ID: 10488531
[TBL] [Abstract][Full Text] [Related]
46. [Molecular composition of phenotypically mixed virions formed during mixed infection with influenza viruses A and B].
Amvros'eva TV; Sklianskaia EI; Varich NL; Kaverin NV
Mol Biol (Mosk); 1984; 18(2):390-6. PubMed ID: 6325868
[TBL] [Abstract][Full Text] [Related]
47. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
Deyde VM; Xu X; Bright RA; Shaw M; Smith CB; Zhang Y; Shu Y; Gubareva LV; Cox NJ; Klimov AI
J Infect Dis; 2007 Jul; 196(2):249-57. PubMed ID: 17570112
[TBL] [Abstract][Full Text] [Related]
48. Children with influenza A infection: treatment with rimantadine.
Hall CB; Dolin R; Gala CL; Markovitz DM; Zhang YQ; Madore PH; Disney FA; Talpey WB; Green JL; Francis AB
Pediatrics; 1987 Aug; 80(2):275-82. PubMed ID: 3302925
[TBL] [Abstract][Full Text] [Related]
49. [Adamantane resistance among influenza A (H3N2) viruses isolated from the mainland of China].
Lan Y; Li Z; Dong LB; Zhang Y; Wen LY; Zhang YM; Wang M; Guo YJ; Shu YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):21-3. PubMed ID: 16816855
[TBL] [Abstract][Full Text] [Related]
50. [Clinical use of the anti-influenza preparation rimantadine].
Zlydnikov DM
Klin Med (Mosk); 1981 Feb; 59(2):109-12. PubMed ID: 7289476
[No Abstract] [Full Text] [Related]
51. Interaction of influenza virus proteins with planar bilayer lipid membranes. II. Effects of rimantadine and amantadine.
Tverdislov VA; El Karadaghi S; Bucher DJ; Zakomirdin JA; Kharitonenkov IG
Biochim Biophys Acta; 1984 Dec; 778(2):276-80. PubMed ID: 6498193
[TBL] [Abstract][Full Text] [Related]
52. [Molecular and genetic analysis of influenza A viruses isolated in Russia, based on the neuraminidase and M2 protein gene sequence].
Rotanov M; Grebennikova TV; Burtseva EI; Shevchenko ES
Mol Gen Mikrobiol Virusol; 2008; (2):27-32. PubMed ID: 18488446
[TBL] [Abstract][Full Text] [Related]
53. Effects of streptovirudin on influenza viruses type A and B: inhibition of the lipid-linked oligosaccharide synthesis of fowl plague virus.
Tonew E; Tonew M; Indulen MK; Dzeguze DR
Acta Virol; 1982 Dec; 26(6):444-52. PubMed ID: 6132539
[TBL] [Abstract][Full Text] [Related]
54. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
[TBL] [Abstract][Full Text] [Related]
55. [Structure and antiviral activity of adamantane-containing polymer preparation].
Kozeletskaia KN; Stotskaia LL; Serbin AV; Munshi K; Sominina AA; Kiselev OI
Vopr Virusol; 2003; 48(5):19-26. PubMed ID: 14598476
[TBL] [Abstract][Full Text] [Related]
56. [The anti-influenza effect of rimantadine and isoprinosine when used in combination in mice].
Pancheva S; Gegova G; Maksimova V; Manolova N
Acta Microbiol Bulg; 1990; 26():26-9. PubMed ID: 1711269
[TBL] [Abstract][Full Text] [Related]
57. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains.
Kuznetsov NY; Tikhov RM; Godovikov IA; Medvedev MG; Lyssenko KA; Burtseva EI; Kirillova ES; Bubnov YN
Org Biomol Chem; 2017 Apr; 15(15):3152-3157. PubMed ID: 28338150
[TBL] [Abstract][Full Text] [Related]
58. [Study of the sensitivity of different strians of the influenza A2 virus of rimantadine].
Pushkarskaia NL; Obrosova-Serova NP; Shenderovich SF; Zaketel'skaia LIa; Galegov GA
Vopr Virusol; 1977; (4):421-4. PubMed ID: 919499
[TBL] [Abstract][Full Text] [Related]
59. [Antigenic characteristics of influenza virus protein M. The ELISA detection of the differences in the M proteins of remantadine-sensitive and -resistant variants of the virus].
Liozner AL; Vorkunova GK; Volynskaia NA; Bukrinskaia AG
Vopr Virusol; 1983; (3):281-6. PubMed ID: 6613083
[TBL] [Abstract][Full Text] [Related]
60. [The mechanisms of the antiviral action of the bora-adamantane derivative preparation BG-12].
Markushin SG; Sinitsyn BV; Ginzburg VP; Khaĭder AM; Klimov AI
Vopr Virusol; 1993; 38(3):122-6. PubMed ID: 8073750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
